Pages that link to "Q85156663"

The following pages link to Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS (Q85156663):

Displaying 18 items.

• Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis (Q28251763) (← links)
• Endogenous and recombinant type I interferons and disease activity in multiple sclerosis (Q28728759) (← links)
• Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosis (Q28740839) (← links)
• Outcome Measures in Clinical Trials for Multiple Sclerosis. (Q31160866) (← links)
• Preliminary study: treatment with intramuscular interferon beta-1a results in increased levels of IL-12Rβ2+ and decreased levels of IL23R+ CD4+ T - Lymphocytes in multiple sclerosis (Q34105985) (← links)
• Enhanced in vivo efficacy of a type I interferon superagonist with extended plasma half-life in a mouse model of multiple sclerosis (Q34355672) (← links)
• Baseline MxA mRNA expression predicts interferon beta response in multiple sclerosis patients. (Q34513928) (← links)
• Endogenous interferon-β-inducible gene expression and interferon-β-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis. (Q35146806) (← links)
• MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patients (Q35148010) (← links)
• Celiac disease: role of intestinal compartments in the mucosal immune response (Q35833970) (← links)
• Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ. (Q36247683) (← links)
• Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance (Q36298955) (← links)
• Inhibition of interferon-beta responses in multiple sclerosis immune cells associated with high-dose statins (Q37543452) (← links)
• Transcriptome sequencing of neurologic diseases associated genes in HHV-6A infected human astrocyte (Q37565386) (← links)
• Determinants of interferon β efficacy in patients with multiple sclerosis (Q37848651) (← links)
• Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. (Q38174450) (← links)
• Predictors of Response to Multiple Sclerosis Therapeutics in Individual Patients (Q38960854) (← links)
• Identifying responders and nonresponders to interferon therapy in multiple sclerosis (Q97570184) (← links)